High levels of BACH2 associated with lower levels of BCL2 transcript abundance in t(14;18)(q21;q34) translocation positive non-Hodgkin's lymphoma

Leukemia Research

Volumn 33, Issue 5, 2009, Pages 731-734

  Green, Michael ^a,b   Gandhi, Maher K ^b,c   Camilleri, Emily ^a   Marlton, Paula ^c   Lea, Rod ^a,d   Griffiths, Lyn ^a,b  

^a GRIFFITH UNIVERSITY   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

Author keywords

BACH2; BCL2; Diffuse large B cell lymphoma; Follicular lymphoma; Non Hodgkin's lymphoma; t(14 ; 18)(q21 ; q34)

Indexed keywords

PROTEIN BCL 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BACH2; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME TRANSLOCATION 14; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE TRANSLOCATION; HUMAN; HUMAN TISSUE; NONHODGKIN LYMPHOMA; PREVALENCE; PRIORITY JOURNAL;

BASE SEQUENCE; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; DNA PRIMERS; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LYMPHOMA, NON-HODGKIN; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; TRANSLOCATION, GENETIC;

EID: 61649105743     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.09.007     Document Type: Article

References (9)

1. Kramer M., Hermans J., Wijburg E., Philippo K., Geelen E., van Krieken J., et al. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood 92 (1998) 3152-3162
2. Muto A., Hoshino H., Madisen L., Yanai N., Obinata M., Karasuyama H., et al. Identification of Bach2 as a B-cell-specific partner for small Maf proteins that negatively regulate the immunoglobulin heavy chain gene 3′ enhancer. EMBO J 17 (1998) 5734-5743
3. Heckman C., Cao T., Somsouk L., Duan H., Mehew J., Zhang C., et al. Critical elements of the immunoglobulin heavy chain enhancers for deregulated expression of Bcl-2. Cancer Res 63 (2003) 6666-6673
4. Alizadeh A., Eisen M., Davis R., Ma C., Lossoss I., Rosenwald A., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403 (2000) 503-511
5. Sakane-Ishikawa E., Nakatsuka S., Tomita Y., Fujita S., Nakamichi I., Takakuwa T., et al. Prognostic significance of BACH2 expression in diffuse large B-cell lymphoma: a study of the Osaka lymphoma study group. J Clin Oncol 23 (2005) 8012-8017
6. Poteat H., and Sklar J. A simplified polymerase chain reaction assay for detection of chromosomal translocations in hematologic malignancies. Diagn Mol Pathol 6 (1997) 3-9
7. -ΔΔCt method. Methods 25 (2001) 402-408
8. Takakuwa T., Luo W., Ham M., Sakane-Ishikawa F., Wada N., and Aozasa K. Integration of Epstein-Barr virus into chromosome 6q15 of Burkitt lymphoma cell line (Raji) induces loss of BACH2 expression. Am J Pathol 164 (2004) 967-974
9. Kamio T., Toki T., Kanezaki R., Sasaki S., Tandai S., Terui K., et al. B-cell-specific transcription factor BACH2 modifies the cytotoxic effects of anticancer drugs. Blood 102 (2003) 3317-3322